Related Experiment Video
Updated: Jul 19, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans
Natalia S Pellegata1, Leticia Quintanilla-Martinez, Heide Siggelkow
1Institutes of Pathology, GSF-National Research Center for Environment and Health, 85764 Neuherberg, Germany. natalia.pellegata@gsf.de
Abstract:
MENX is a recessive multiple endocrine neoplasia-like syndrome in the rat. The tumor spectrum in MENX overlaps those of human multiple endocrine neoplasia (MEN) types 1 and 2. We mapped the MenX locus to the distal part of rat chromosome 4, excluding the homologs of the genes responsible for the MEN syndromes (RET and MEN1) and syndromes with an endocrine tumor component (VHL and NF1). We report the fine mapping of the disease locus and the identification of a homozygous frameshift mutation in Cdkn1b, encoding the cyclin-dependent kinase inhibitor p27(Kip1). As a consequence of the mutation, MENX-affected rats show dramatic reduction in p27(Kip1) protein. We have identified a germ-line nonsense mutation in the human CDKN1B gene in a MEN1 mutation-negative patient presenting with pituitary and parathyroid tumors. Expanded pedigree analysis shows that the mutation is associated with the development of an MEN1-like phenotype in multiple generations. Our findings demonstrate that germ-line mutations in p27(Kip1) can predispose to the development of multiple endocrine tumors in both rats and humans.
Insights
Multiple endocrine neoplasia-like syndrome (MENX) in rats is caused by a Cdkn1b mutation, leading to reduced p27(Kip1). A similar mutation in human CDKN1B predisposes to endocrine tumors, linking p27(Kip1) to multiple endocrine neoplasia.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Multiple endocrine neoplasia (MEN) syndromes involve tumors in endocrine glands.
- MENX in rats shares tumor characteristics with human MEN types 1 and 2.
- Previous mapping excluded known MEN-associated genes.
Purpose of the Study:
- To fine-map the MenX locus in rats.
- To identify the genetic cause of MENX.
- To investigate the role of p27(Kip1) in endocrine tumorigenesis.
Main Methods:
- Fine genetic mapping of the MenX locus on rat chromosome 4.
- Mutation analysis of the Cdkn1b gene in affected rats.
- Germline mutation screening of the human CDKN1B gene in MEN1-negative patients.
Main Results:
- A homozygous frameshift mutation in rat Cdkn1b was identified in MENX rats, causing a p27(Kip1) protein reduction.
- A germline nonsense mutation in human CDKN1B was found in a MEN1-negative patient with pituitary and parathyroid tumors.
- Pedigree analysis confirmed the association of the human CDKN1B mutation with an MEN1-like phenotype.
Conclusions:
- Germline mutations in p27(Kip1) are implicated in the development of multiple endocrine tumors.
- Cdkn1b mutations can cause MENX in rats and contribute to MEN1-like syndromes in humans.
- p27(Kip1) is a key factor in endocrine tumor predisposition.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Related Concept Videos
The Ras Gene
Ras is a superfamily...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...